Compensatory Increase in Ovarian Aromatase in Older Regularly Cycling Women
Overview
Affiliations
Context: Serum estradiol (E2) levels are preserved in older reproductive-aged women with regular menstrual cycles despite declining ovarian function.
Objective: The objective of the study was to determine whether increased granulosa cell aromatase expression and activity account for preservation of E2 levels in older, regularly cycling women.
Design: The protocol included daily blood sampling and dominant follicle aspirations at an academic medical center during a natural menstrual cycle.
Subjects: Healthy, regularly cycling older (36-45 y; n = 13) and younger (22-34 y; n = 14) women participated in the study.
Main Outcome Measures: Hormone levels were measured in peripheral blood and follicular fluid aspirates and granulosa cell CYP19A1 (aromatase) and FSH-R mRNA expression were determined.
Results: Older women had higher FSH levels than younger women during the early follicular phase with similar E2 but lower inhibin B and antimullerian hormone levels. Late follicular phase serum E2 did not differ between the two groups. Follicular fluid E2 [older (O) = 960.0 [interquartile range (IQR) 765.0-1419.0]; younger (Y) = 994.5 [647.3-1426.5] ng/mL, P = 1.0], estrone (O = 39.6 [29.5-54.1]; Y = 28.8 [22.5-42.1] ng/mL, P = 0.3), and the E2 to testosterone (T) ratio (O = 109.0 ± 41.9; Y = 83.0 ± 18.6, P = .50) were preserved in older women. Granulosa cell CYP19A1 expression was increased 3-fold in older compared with younger women (P < .001), with no difference in FSH-R expression.
Conclusions: Ovarian aromatase expression increases with age in regularly cycling women. Thus, up-regulation of aromatase activity appears to compensate for the known age-related decrease in granulosa cell number in the dominant follicle to maintain ovarian estrogen production in older premenopausal women.
Hormones and Aging: An Endocrine Society Scientific Statement.
Cappola A, Auchus R, Fuleihan G, Handelsman D, Kalyani R, McClung M J Clin Endocrinol Metab. 2023; 108(8):1835-1874.
PMID: 37326526 PMC: 11491666. DOI: 10.1210/clinem/dgad225.
Arafah M, Aldawood N, Alrezaki A, Nahdi S, Alwasel S, Mansour L Physiol Res. 2022; 72(1):59-69.
PMID: 36545876 PMC: 10069810. DOI: 10.33549/physiolres.934975.
GnRH agonist-triggering ovulation in women with advanced age.
Koren R, Miller N, Moran R, Decter D, Berkowitz A, Herzberger E Sci Rep. 2022; 12(1):16401.
PMID: 36180515 PMC: 9525572. DOI: 10.1038/s41598-022-20619-4.
Allshouse A, Pavlovic J, Santoro N Obstet Gynecol Clin North Am. 2018; 45(4):613-628.
PMID: 30401546 PMC: 6226272. DOI: 10.1016/j.ogc.2018.07.004.
Santoro N, Crawford S, El Khoudary S, Allshouse A, Burnett-Bowie S, Finkelstein J J Clin Endocrinol Metab. 2017; 102(7):2218-2229.
PMID: 28368525 PMC: 5505186. DOI: 10.1210/jc.2016-4017.